The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2017

Filed:

Nov. 14, 2014
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Upender Velaparthi, Cheshire, CT (US);

Chetan Padmakar Darne, Orange, CT (US);

Peiying Liu, Madison, CT (US);

Mark D. Wittman, Wallingford, CT (US);

Bradley C. Pearce, East Hampton, CT (US);

Erika M. V. Araujo, Woodbridge, CT (US);

Bireshwar Dasgupta, East Hampton, CT (US);

Jalathi Surendran Nair, Bangalore, IN;

Sakthi Kumaran Janakiraman, Bangalore, IN;

Chandrasekhar Reddy Rachamreddy, Bangalore, IN;

Mallikarjuna Rao Mettu, Bangalore, IN;

Arul Mozhi Selvan Subbiah Karuppiah, Bangalore, IN;

Bandreddy Subba Reddy, Bangalore, IN;

Pulicharla Nagalakshmi, Bangalore, IN;

Rajesh Onkardas Bora, Bangalore, IN;

Shilpa Holehatti Maheshwarappa, Davanagere District, IN;

Selvakumar Kumaravel, Bangalore, IN;

Dibakar Mullick, Howrah District, IN;

Ramesh Sistla, Bangalore, IN;

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/498 (2006.01); C07D 487/04 (2006.01); C07D 491/147 (2006.01); C07D 487/10 (2006.01); C07D 491/20 (2006.01); C07D 487/20 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); C07D 487/10 (2013.01); C07D 487/20 (2013.01); C07D 491/147 (2013.01); C07D 491/20 (2013.01); C07D 519/00 (2013.01);
Abstract

The invention provides compounds of Formula (I): and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.


Find Patent Forward Citations

Loading…